Published in Diabetes Care on June 07, 2008
International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care (2009) 26.77
Standards of medical care in diabetes--2013. Diabetes Care (2013) 24.85
Standards of medical care in diabetes--2010. Diabetes Care (2010) 24.28
Standards of medical care in diabetes--2011. Diabetes Care (2011) 21.94
Standards of medical care in diabetes--2012. Diabetes Care (2012) 20.66
Standards of medical care in diabetes--2009. Diabetes Care (2009) 15.78
A bihormonal closed-loop artificial pancreas for type 1 diabetes. Sci Transl Med (2010) 5.67
Glucose levels and risk of dementia. N Engl J Med (2013) 4.95
Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N Engl J Med (2014) 3.38
Screening for diabetes and pre-diabetes with proposed A1C-based diagnostic criteria. Diabetes Care (2010) 3.12
Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care (2011) 2.75
A1C versus glucose testing: a comparison. Diabetes Care (2011) 2.37
A1C level and future risk of diabetes: a systematic review. Diabetes Care (2010) 2.35
Magnitude of the dawn phenomenon and its impact on the overall glucose exposure in type 2 diabetes: is this of concern? Diabetes Care (2013) 2.17
Impact of blood glucose self-monitoring errors on glucose variability, risk for hypoglycemia, and average glucose control in type 1 diabetes: an in silico study. J Diabetes Sci Technol (2010) 1.99
The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial. Diabetes Care (2015) 1.93
Racial and ethnic differences in the relationship between HbA1c and blood glucose: implications for the diagnosis of diabetes. J Clin Endocrinol Metab (2012) 1.87
Diabetic kidney disease: a report from an ADA Consensus Conference. Diabetes Care (2014) 1.79
Relationship between A1C and glucose levels in the general Dutch population: the new Hoorn study. Diabetes Care (2009) 1.77
Effect of pramlintide on prandial glycemic excursions during closed-loop control in adolescents and young adults with type 1 diabetes. Diabetes Care (2012) 1.63
High-fat diet accelerates progression of osteoarthritis after meniscal/ligamentous injury. Arthritis Res Ther (2011) 1.62
Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial. Lancet Diabetes Endocrinol (2016) 1.59
Pitfalls in the use of HbA₁(c) as a diagnostic test: the ethnic conundrum. Nat Rev Endocrinol (2010) 1.52
Assessing glycemic control in maintenance hemodialysis patients with type 2 diabetes. Diabetes Care (2009) 1.49
Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial. Int J Clin Pract (2009) 1.47
Associations between features of glucose exposure and A1C: the A1C-Derived Average Glucose (ADAG) study. Diabetes (2010) 1.45
Weight neutrality with the DPP-4 inhibitor, vildagliptin: mechanistic basis and clinical experience. Vasc Health Risk Manag (2010) 1.45
Early basal insulin therapy decreases new-onset diabetes after renal transplantation. J Am Soc Nephrol (2012) 1.44
Measurement of hemoglobin A(1c): a new twist on the path to harmony. Diabetes Care (2012) 1.43
A1C underestimates glycemia in HIV infection. Diabetes Care (2009) 1.41
Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes. Metabolism (2011) 1.41
Effects of a new combination of nutraceuticals with Morus alba on lipid profile, insulin sensitivity and endotelial function in dyslipidemic subjects. A cross-over, randomized, double-blind trial. High Blood Press Cardiovasc Prev (2015) 1.40
Guidelines for optimal bolus calculator settings in adults. J Diabetes Sci Technol (2011) 1.37
Relationship of glycated albumin to blood glucose and HbA1c values and to retinopathy, nephropathy, and cardiovascular outcomes in the DCCT/EDIC study. Diabetes (2013) 1.37
Regional, geographic, and racial/ethnic variation in glycemic control in a national sample of veterans with diabetes. Diabetes Care (2011) 1.37
No racial differences in the association of glycated hemoglobin with kidney disease and cardiovascular outcomes. Diabetes Care (2013) 1.33
Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis. Diabetes Care (2015) 1.32
Implications of using hemoglobin A1C for diagnosing diabetes mellitus. Am J Med (2011) 1.30
Autonomous and continuous adaptation of a bihormonal bionic pancreas in adults and adolescents with type 1 diabetes. J Clin Endocrinol Metab (2014) 1.29
Diabetes and employment. Diabetes Care (2013) 1.28
Back to Wilson and Jungner: 10 good reasons to screen for type 2 diabetes mellitus. Mayo Clin Proc (2009) 1.26
Carbamylation of serum albumin as a risk factor for mortality in patients with kidney failure. Sci Transl Med (2013) 1.25
A feasibility study of bihormonal closed-loop blood glucose control using dual subcutaneous infusion of insulin and glucagon in ambulatory diabetic swine. J Diabetes Sci Technol (2009) 1.25
2010 consensus statement on the worldwide standardization of the hemoglobin A1C measurement. Diabetes Care (2010) 1.23
Sixty-five common genetic variants and prediction of type 2 diabetes. Diabetes (2014) 1.21
HbA1c for the diagnosis of diabetes and prediabetes: is it time for a mid-course correction? J Clin Endocrinol Metab (2010) 1.21
The clinical use of hemoglobin A1c. J Diabetes Sci Technol (2009) 1.21
A review of the challenge in measuring hemoglobin A1c. J Diabetes Sci Technol (2009) 1.20
HbA₁(c) and mean blood glucose show stronger associations with cardiovascular disease risk factors than do postprandial glycaemia or glucose variability in persons with diabetes: the A1C-Derived Average Glucose (ADAG) study. Diabetologia (2010) 1.20
Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus. Cardiovasc Diabetol (2013) 1.18
The effect of iron and erythropoietin treatment on the A1C of patients with diabetes and chronic kidney disease. Diabetes Care (2010) 1.16
Pitfalls in hemoglobin A1c measurement: when results may be misleading. J Gen Intern Med (2013) 1.14
Hemoglobin A1c and mean glucose in patients with type 1 diabetes: analysis of data from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial. Diabetes Care (2011) 1.13
A closed-loop artificial pancreas based on risk management. J Diabetes Sci Technol (2011) 1.12
Glucose-independent ethnic differences in HbA1c in people without known diabetes. Diabetes Care (2012) 1.12
Empirically establishing blood glucose targets to achieve HbA1c goals. Diabetes Care (2014) 1.11
Circulating biomarkers of glycemia in diabetes management and implications for personalized medicine. J Diabetes Sci Technol (2009) 1.11
Biologic variability in plasma glucose, hemoglobin A1c, and advanced glycation end products associated with diabetes complications. J Diabetes Sci Technol (2009) 1.08
Accuracy and robustness of dynamical tracking of average glycemia (A1c) to provide real-time estimation of hemoglobin A1c using routine self-monitored blood glucose data. Diabetes Technol Ther (2013) 1.08
Ethnic differences in glycemic markers in patients with type 2 diabetes. Diabetes Care (2013) 1.07
The Diabetes Self-Management Questionnaire (DSMQ): development and evaluation of an instrument to assess diabetes self-care activities associated with glycaemic control. Health Qual Life Outcomes (2013) 1.06
When the blood glucose and the HbA(1c) don't match: turning uncertainty into opportunity. Diabetes Care (2012) 1.05
Glycated hemoglobin predicts all-cause, cardiovascular, and cancer mortality in people without a history of diabetes undergoing coronary angiography. Diabetes Care (2011) 1.05
Validity of glycated hemoglobin in screening and diagnosing type 2 diabetes mellitus in Chinese subjects. Korean J Intern Med (2012) 1.05
Multinational Internet-based survey of patient preference for newer oral or injectable Type 2 diabetes medication. Patient Prefer Adherence (2010) 1.04
Biomarkers in diabetes: hemoglobin A1c, vascular and tissue markers. Transl Res (2012) 1.03
A Comparison of HbA1c and Fasting Blood Sugar Tests in General Population. Int J Prev Med (2010) 1.03
HbA(1c) levels in schoolchildren with type 1 diabetes are seasonally variable and dependent on weather conditions. Diabetologia (2010) 1.01
Persistence of individual variations in glycated hemoglobin: analysis of data from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Randomized Trial. Diabetes Care (2011) 1.00
Translating the A1C Assay. Diabetes Care (2008) 1.00
Effect of moderate-intensity exercise versus activities of daily living on 24-hour blood glucose homeostasis in male patients with type 2 diabetes. Diabetes Care (2013) 0.99
Low hemoglobin A(1c) in nondiabetic adults: an elevated risk state? Diabetes Care (2012) 0.98
Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profile. J Diabetes Sci Technol (2013) 0.97
Estimated average glucose and self-monitored mean blood glucose are discordant estimates of glycemic control. Diabetes Care (2010) 0.95
The prevention and control the type-2 diabetes by changing lifestyle and dietary pattern. J Educ Health Promot (2014) 0.95
Design of a decision support system to help clinicians manage glycemia in patients with type 2 diabetes mellitus. J Diabetes Sci Technol (2011) 0.95
Probabilistic evolving meal detection and estimation of meal total glucose appearance. J Diabetes Sci Technol (2009) 0.94
Implications of rising prediabetes prevalence. Diabetes Care (2013) 0.94
Does glucose variability influence the relationship between mean plasma glucose and HbA1c levels in type 1 and type 2 diabetic patients? Diabetes Care (2011) 0.94
Family therapy for adolescents with poorly controlled diabetes: initial test of clinical significance. J Pediatr Psychol (2009) 0.94
The Diabetes Control and Complications Trial: the gift that keeps giving. Nat Rev Endocrinol (2009) 0.94
Standardized Glycemic Management with a Computerized Workflow and Decision Support System for Hospitalized Patients with Type 2 Diabetes on Different Wards. Diabetes Technol Ther (2015) 0.94
Is there a relationship between mean blood glucose and glycated hemoglobin? J Diabetes Sci Technol (2011) 0.94
Metabolic syndrome and cognitive decline among the oldest old in Okinawa: in search of a mechanism. The KOCOA Project. J Gerontol A Biol Sci Med Sci (2011) 0.93
A survey of patient preferences for oral antihyperglycemic therapy in patients with type 2 diabetes mellitus. Diabetes Ther (2015) 0.92
Rapid improvement of glycemic control in type 2 diabetes using weekly intensive multifactorial interventions: structured glucose monitoring, patient education, and adjustment of therapy-a randomized controlled trial. Diabetes Technol Ther (2011) 0.92
Association of cardiovascular burden with mobility limitation among elderly people: a population-based study. PLoS One (2013) 0.92
Circulating oxidized low-density lipoproteins and arterial elasticity: comparison between men with metabolic syndrome and physically active counterparts. Cardiovasc Diabetol (2010) 0.92
Do race and ethnicity impact hemoglobin A1c independent of glycemia? J Diabetes Sci Technol (2009) 0.92
The long and winding road to optimal HbA1c measurement. Clin Chim Acta (2013) 0.91
We can change the natural history of type 2 diabetes. Diabetes Care (2014) 0.91
Hemoglobin A1c, fasting plasma glucose, and 2-hour plasma glucose distributions in U.S. population subgroups: NHANES 2005-2010. Ann Epidemiol (2013) 0.90
Usefulness of Glycemic Gap to Predict ICU Mortality in Critically Ill Patients With Diabetes. Medicine (Baltimore) (2015) 0.89
ADAG study group data links A1C levels with empirically measured blood glucose values - new treatment guidelines will now be needed. J Diabetes Sci Technol (2014) 0.89
Real-life glycaemic profiles in non-diabetic individuals with low fasting glucose and normal HbA1c: the A1C-Derived Average Glucose (ADAG) study. Diabetologia (2010) 0.88
Influence of Acarbose on Plasma Glucose Fluctuations in Insulin-Treated Patients with Type 2 Diabetes: A Pilot Study. Int J Endocrinol (2015) 0.87
Inpatient trial of an artificial pancreas based on multiple model probabilistic predictive control with repeated large unannounced meals. Diabetes Technol Ther (2014) 0.87
Glycemic variability: Clinical implications. Indian J Endocrinol Metab (2013) 0.87
Glycemic control and urinary incontinence in women with diabetes mellitus. J Womens Health (Larchmt) (2013) 0.86
Translating the A1C assay into estimated average glucose values: response to Nathan et al. Diabetes Care (2009) 0.86
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med (1993) 102.56
Standards of medical care in diabetes--2007. Diabetes Care (2007) 12.35
Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care (2006) 9.87
The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes (1995) 8.89
Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus. N Engl J Med (1976) 7.02
Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. Diabetes Care (2002) 6.15
The clinical information value of the glycosylated hemoglobin assay. N Engl J Med (1984) 4.79
Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c. JAMA (2006) 4.27
The national glycohemoglobin standardization program: a five-year progress report. Clin Chem (2001) 4.24
IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem (2004) 4.02
Approved IFCC reference method for the measurement of HbA1c in human blood. Clin Chem Lab Med (2002) 3.75
Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem (2001) 3.63
Relationship between glycated haemoglobin levels and mean glucose levels over time. Diabetologia (2007) 3.49
Tests of glycemia in diabetes. Diabetes Care (2004) 3.35
A desktop guide to Type 2 diabetes mellitus. European Diabetes Policy Group 1999. Diabet Med (1999) 3.09
High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control. J Diabetes Complications (2002) 2.42
Relationship of A1C to glucose concentrations in children with type 1 diabetes: assessments by high-frequency glucose determinations by sensors. Diabetes Care (2007) 2.20
Comparison of the accuracy of the HemoCue glucose analyzer with the Yellow Springs Instrument glucose oxidase analyzer, particularly in hypoglycemia. Eur J Endocrinol (2005) 1.71
Psychological impact of changing the scale of reported HbA(1c) results affects metabolic control. Diabetes Care (2002) 1.58
Glycosylated haemoglobin and steady-state mean blood glucose concentration in Type 1 (insulin-dependent) diabetes. Diabetologia (1982) 1.54
Global harmonization of hemoglobin A1c. Clin Chem (2005) 1.36
Contributions of weekly mean blood glucose values to hemoglobin A1c in insulin-treated type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES). Am J Med Sci (2004) 1.30
Feasibility of improved blood glucose control in patients with insulin-dependent diabetes mellitus. Diabetes Care (1980) 1.21
Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med (2000) 48.03
Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med (2004) 11.78
The US National Comorbidity Survey Replication (NCS-R): design and field procedures. Int J Methods Psychiatr Res (2004) 10.47
Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care (2006) 9.87
Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. Diabetes Care (2005) 8.94
Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Lancet (2010) 8.27
Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med (2006) 7.97
Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination. Vaccine (2009) 6.30
Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care (2007) 6.24
Clinical calibration of DSM-IV diagnoses in the World Mental Health (WMH) version of the World Health Organization (WHO) Composite International Diagnostic Interview (WMHCIDI). Int J Methods Psychiatr Res (2004) 6.04
MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell (2011) 5.91
Randomized, placebo-controlled clinical trial of an aerosolized β₂-agonist for treatment of acute lung injury. Am J Respir Crit Care Med (2011) 5.24
Glucose levels and risk of dementia. N Engl J Med (2013) 4.95
[Human natural infection of Plasmodium knowlesi]. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi (2006) 3.99
Pancreatic ductal adenocarcinoma: long-term survival does not equal cure. Surgery (2012) 3.87
L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials. Am J Psychiatry (2012) 3.73
CD4 decline and incidence of opportunistic infections in Cape Town, South Africa: implications for prophylaxis and treatment. J Acquir Immune Defic Syndr (2006) 3.39
Prospective study of bevacizumab plus temozolomide in patients with advanced neuroendocrine tumors. J Clin Oncol (2012) 3.36
Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med (2004) 3.26
Whole blood and leukocyte RNA isolation for gene expression analyses. Physiol Genomics (2004) 3.22
Moderate alcohol consumption lowers the risk of type 2 diabetes: a meta-analysis of prospective observational studies. Diabetes Care (2005) 3.19
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis. Nat Med (2011) 3.16
Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Diabetes Metab Res Rev (2006) 3.06
Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c. Diabetes Care (2004) 3.03
Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels: the Hoorn study. Diabetes Care (2004) 3.02
Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci U S A (2004) 2.99
Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study. Atherosclerosis (2006) 2.95
Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet Neurol (2010) 2.91
Dimorphic effects of Notch signaling in bone homeostasis. Nat Med (2008) 2.82
One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial. Diabetes Care (2009) 2.75
Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study. Arch Ophthalmol (2003) 2.74
Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn Study. Am J Clin Nutr (2003) 2.70
Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation (2005) 2.66
Increased cardiovascular disease risk indices in HIV-infected women. J Acquir Immune Defic Syndr (2005) 2.63
Effects of recruitment maneuvers in patients with acute lung injury and acute respiratory distress syndrome ventilated with high positive end-expiratory pressure. Crit Care Med (2003) 2.63
Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. J Infect Dis (2009) 2.62
Pancreatic fat content and beta-cell function in men with and without type 2 diabetes. Diabetes Care (2007) 2.61
A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control. Diabetes Care (2002) 2.51
Optimizing resource allocation in United States AIDS drug assistance programs. Clin Infect Dis (2006) 2.45
An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study. Lancet Neurol (2013) 2.43
Presenilin couples the paired phosphorylation of beta-catenin independent of axin: implications for beta-catenin activation in tumorigenesis. Cell (2002) 2.37
Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis. Arch Gen Psychiatry (2005) 2.35
The effect of angiotensin-blocking agents on liver fibrosis in patients with hepatitis C. Liver Int (2009) 2.33
Predictors of mortality in patients initiating antiretroviral therapy in Durban, South Africa. S Afr Med J (2008) 2.30
Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Abeta 42 production. Proc Natl Acad Sci U S A (2002) 2.29
Arterial stiffness increases with deteriorating glucose tolerance status: the Hoorn Study. Circulation (2003) 2.28
Beyond mortality: future clinical research in acute lung injury. Am J Respir Crit Care Med (2010) 2.28
Effect of moderate alcohol consumption on adiponectin, tumor necrosis factor-alpha, and insulin sensitivity. Diabetes Care (2004) 2.24
Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study. Lancet Oncol (2009) 2.23
Exercise-induced ST-segment elevation in ECG lead aVR is a useful indicator of significant left main or ostial LAD coronary artery stenosis. JACC Cardiovasc Imaging (2011) 2.21
Defective neuromuscular synapses in mice lacking amyloid precursor protein (APP) and APP-Like protein 2. J Neurosci (2005) 2.21
Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study. Kidney Int (2002) 2.18
A negative feedback loop of transcription factors that controls stem cell pluripotency and self-renewal. FASEB J (2006) 2.17
Hepatitis C virus infection and its clearance alter circulating lipids: implications for long-term follow-up. Hepatology (2009) 2.13
Comparison of analysis approaches for phase III clinical trials in amyotrophic lateral sclerosis. Muscle Nerve (2012) 2.13
Cardiovascular events in type 2 diabetes: comparison with nondiabetic individuals without and with prior cardiovascular disease. 10-year follow-up of the Hoorn Study. Eur Heart J (2003) 2.03
An estimator for treatment comparisons among survivors in randomized trials. Biometrics (2005) 2.00
Increased central artery stiffness in impaired glucose metabolism and type 2 diabetes: the Hoorn Study. Hypertension (2003) 2.00
A comparative effectiveness analysis of three continuous glucose monitors. Diabetes Care (2012) 1.97
Lapsing during sleep deprivation is associated with distributed changes in brain activation. J Neurosci (2008) 1.92
The effects of isoflurane and desflurane on cognitive function in humans. Anesth Analg (2011) 1.88
Acupuncture for migraine prophylaxis: a randomized controlled trial. CMAJ (2012) 1.87
Comparison of positron emission tomography measurement of adenosine-stimulated absolute myocardial blood flow versus relative myocardial tracer content for physiological assessment of coronary artery stenosis severity and location. JACC Cardiovasc Imaging (2009) 1.84
Diabetes, pulse pressure and cardiovascular mortality: the Hoorn Study. J Hypertens (2002) 1.83
Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods. J Clin Endocrinol Metab (2004) 1.81
Decreased dissolution of ZnO by iron doping yields nanoparticles with reduced toxicity in the rodent lung and zebrafish embryos. ACS Nano (2011) 1.75
A novel tool for the assessment of pain: validation in low back pain. PLoS Med (2009) 1.75
Effects of risedronate and low-dose transdermal testosterone on bone mineral density in women with anorexia nervosa: a randomized, placebo-controlled study. J Clin Endocrinol Metab (2011) 1.74
Non-high-density lipoprotein cholesterol as a biomarker for nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol (2012) 1.74
Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetes. PLoS One (2012) 1.74
Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes. Diabetes (2006) 1.74
The anesthetic considerations of tracheobronchial foreign bodies in children: a literature review of 12,979 cases. Anesth Analg (2010) 1.74
Use of a high-throughput screening approach coupled with in vivo zebrafish embryo screening to develop hazard ranking for engineered nanomaterials. ACS Nano (2011) 1.68
The effect of acute hyperglycemia on retinal thickness and ocular refraction in healthy subjects. Graefes Arch Clin Exp Ophthalmol (2008) 1.67
Mortality on Mount Everest, 1921-2006: descriptive study. BMJ (2008) 1.66
Presynaptic and postsynaptic interaction of the amyloid precursor protein promotes peripheral and central synaptogenesis. J Neurosci (2009) 1.65
Presenilin 1 mediates the turnover of telencephalin in hippocampal neurons via an autophagic degradative pathway. J Cell Biol (2004) 1.65
GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype. J Infect Dis (2006) 1.64
Potentially modifiable determinants of vitamin D status in an older population in the Netherlands: the Hoorn Study. Am J Clin Nutr (2007) 1.63
Predictors of antiretroviral treatment failure in an urban HIV clinic. J Acquir Immune Defic Syndr (2007) 1.61
Blood pressure, lipids, and obesity are associated with retinopathy: the hoorn study. Diabetes Care (2002) 1.60
Phase 1/2 study of everolimus in advanced hepatocellular carcinoma. Cancer (2011) 1.59
Estimated glomerular filtration rate and urinary albumin excretion are independently associated with greater arterial stiffness: the Hoorn Study. J Am Soc Nephrol (2007) 1.58
Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation (2005) 1.56
Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the hoorn study. Diabetes Care (2006) 1.56
Structural basis for the prion-like MAVS filaments in antiviral innate immunity. Elife (2014) 1.56
Widespread muscle expression of an AAV9 human mini-dystrophin vector after intravenous injection in neonatal dystrophin-deficient dogs. Mol Ther (2010) 1.56
Fluid management with a simplified conservative protocol for the acute respiratory distress syndrome*. Crit Care Med (2015) 1.55
Accelerated plaque accumulation, associative learning deficits, and up-regulation of alpha 7 nicotinic receptor protein in transgenic mice co-expressing mutant human presenilin 1 and amyloid precursor proteins. J Biol Chem (2002) 1.54
Local extension at the hilum region is associated with worse long-term survival in stage I non-small cell lung cancers. Ann Thorac Surg (2011) 1.53
Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2008) 1.53
Effects of exenatide on measures of β-cell function after 3 years in metformin-treated patients with type 2 diabetes. Diabetes Care (2011) 1.53
Refractive properties of the healthy human eye during acute hyperglycemia. Graefes Arch Clin Exp Ophthalmol (2008) 1.51
Global TravEpiNet: a national consortium of clinics providing care to international travelers--analysis of demographic characteristics, travel destinations, and pretravel healthcare of high-risk US international travelers, 2009-2011. Clin Infect Dis (2011) 1.51
Vitamin D and mortality in older men and women. Clin Endocrinol (Oxf) (2009) 1.50
Microalbuminuria is associated with impaired brachial artery, flow-mediated vasodilation in elderly individuals without and with diabetes: further evidence for a link between microalbuminuria and endothelial dysfunction--the Hoorn Study. Kidney Int Suppl (2004) 1.50
A replicable method for blood glucose control in critically Ill patients. Crit Care Med (2008) 1.50